Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

January 16, 2022

Tanshinone IIA and its derivative activate thermogenesis in adipocytes and induce "beiging" of white adipose tissue.

Molecular and Cellular Endocrinology
Lei MaZhonghan Yang
January 16, 2022

Role of anatomical location, cellular phenotype and perfusion of adipose tissue in intermediary metabolism: A narrative review.

Reviews in Endocrine & Metabolic Disorders
Stefania Camastra, Ele Ferrannini
January 16, 2022

Adipocyte GPX4 protects against inflammation, hepatic insulin resistance and metabolic dysregulation.

International Journal of Obesity : Journal of the International Association for the Study of Obesity
Julian SchwärzlerTimon E Adolph
January 16, 2022
Open Access

Iron chelation increases beige fat differentiation and metabolic activity, preventing and treating obesity.

Scientific Reports
Mojgan NazariJenny E Gunton
January 16, 2022
Open Access

Meta-analysis links dietary branched-chain amino acids to metabolic health in rodents.

BMC Biology
Samantha M Solon-BietAlistair M Senior
January 15, 2022

Effects of body weight and fat mass on back pain - direct mechanical or indirect through inflammatory and metabolic parameters?

Seminars in Arthritis and Rheumatism
Romain S PereraMaja R Radojčić
January 15, 2022

Vitamin D deficiency: a potential risk factor for cancer in obesity?

International Journal of Obesity : Journal of the International Association for the Study of Obesity
Silvia MigliaccioSilvia Savastano
January 15, 2022

Identification of a regulatory pathway inhibiting adipogenesis via RSPO2.

Nature Metabolism
Hua DongChristian Wolfrum
January 15, 2022

Beneficial effects of Ilex paraguariensis in the prevention of obesity-associated metabolic disorders in mice.

Phytotherapy Research : PTR
Helber da Maia ValençaManuella Lanzetti
January 14, 2022

Impact of sports participation on components of metabolic syndrome in adolescents: ABCD growth study.

Journal of Pediatric Endocrinology & Metabolism : JPEM
Veronica Alves de MenezesRomulo Araujo Fernandes
January 14, 2022

Treatment with Soluble Activin Type IIB Receptor Ameliorates Ovariectomy-Induced Bone Loss and Fat Gain in Mice.

Calcified Tissue International
Tero PuolakkainenRiku Kiviranta
January 14, 2022

Polymorphism detection of DGAT1 and Lep genes in Anatolian water buffalo (Bubalus bubalis) populations in Turkey.

Archives Animal Breeding
Raziye IşıkM İhsan Soysal
January 14, 2022

Ginsenoside Rb1 Protects Against Diabetic Cardiomyopathy by Regulating the Adipocytokine Pathway.

Journal of Inflammation Research
Chenyang ZhangGuibo Sun
January 14, 2022

Mice Lacking Gpr75 are Hypophagic and Thin.

Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
David R PowellMelanie K Shadoan
January 14, 2022

[Anthropometric indicators and poor glycemic control in type 2 diabetes with kidney disease].

Revista médica del Instituto Mexicano del Seguro Social
Lubia Velázquez-LópezLuisa Díaz-García
January 14, 2022

Asprosin and Oxidative Stress Level in COVID-19 Patients.

Clinical Laboratory
E Sabri SeyhanliEbru Temiz
January 14, 2022

Orexin, serotonin, and energy balance.

WIREs Mechanisms of Disease
Vijayakumar MavanjiCatherine M Kotz
January 14, 2022

Kisspeptin and the Genetic Obesity Interactome.

Advances in Experimental Medicine and Biology
Geronikolou SGeorge P Chrousos

Sign up to follow this feed and discover related papers.

Related Feeds

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

COVID-19 & Diabetes (ADA)

COVID-19 (short for “Coronavirus Disease 2019") is the disease caused by the novel coronavirus, SARS-CoV-2. Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes. To keep our community as informed as possible, the American Diabetes Association is partnering with the Chan Zuckerberg Initiative's Meta to highlight the latest research developments at the intersection of COVID-19 and diabetes.

© 2022 Meta ULC. All rights reserved